The upregulation of PD-1 on tumor-infiltrating lymphocytes (TILs) and the increased expression of its ligands on tumor cells have been linked to tumor immune evasion, resulting in the suppression of tumor-specific CD8+ T cells. Here, PDCD1 is linked to neoplasm.